Rob Copeland

Rob Copeland has followed Bridgewater since arriving at the WSJ in 2013. He has interviewed dozens of current and former Bridgewater employees, including Dalio, and many of his erstwhile heirs apparent. In 2020, Copeland wrote one of the most viewed stories in recent WSJ memory, a front-page story about the private Manhattan Project to develop a vaccine for Covid-19. The Fund is his first book.

Rob Copeland has followed Bridgewater since arriving at the WSJ in 2013. He has interviewed dozens of current and former Bridgewater employees, including Dalio, and many of his erstwhile heirs apparent. In 2020, Copeland wrote one of the most viewed stories in recent WSJ memory, a front-page story about the private Manhattan Project to develop a vaccine for Covid-19. The Fund is his first book. See less